The New GI-MAP Microbial Markers - What Clinicians Need to Know
Please Note: GI-MAP has been further enhanced since this post was published in 2018.
Additional test information is available at: GI-MAP™ Enhanced with New Bacterial Biomarkers (2019)
Additional test information is available at: The Industry's Leading Comprehensive Stool Test Just Got Better! (2022)
The GI-MAP™ comprehensive stool analysis now includes four new commensal and opportunistic biomarkers (A. muciniphila, F. prausnitzii, Methanobacteriaceae (family), and Fusobacterium spp.). The carefully curated new biomarkers provide enhanced clinical insights based on the latest medical research. Further, the additional markers were added based on their ability to be modified using known clinical approaches.
In this presentation, Dr. Tom Fabian, will take clinicians on a marker-by-marker journey that explains the significance the new markers have on patient health, how to interpret them, and how to work with them in clinical practice.
Presented by Tom Fabian, PhD, CNTP:
Tom is a functional nutrition practitioner, consultant, educator, speaker, and former research scientist. His primary expertise is in how the microbiome interacts with the digestive, immune and nervous systems, and how it influences metabolic processes. He has developed online educational programs for practitioners seeking in-depth education in the microbiome and related topics. He also has extensive experience in the areas of aging and healthspan optimization, both through his previous research experience as well as his more recent experience as a functional health practitioner.